After several years of R&D and clinical development, Anecova has developed a more natural approach to assisted reproductive technology with the development of a porous capsule device allowing bi-directional passage of fluids, nutrients, endometrial cells and other cellular and non-cellular components, to enable interaction between the embryos and the maternal environment. It allows fertilisation and early embryo development in the maternal environment.
Martin Velasco, Founder, Chairman and CEO of Anecova, says: “Complete Fertility Centre, under the leadership of Professor Nick Macklon, has developed a unique level of excellence in patient care in IVF, combined with state of the art, innovative, patient centric research. We are delighted that Complete Fertility Centre is offering to its patients the Natural Fertilisation procedure based on our AneVivo device”.
Complete Fertility Centre is at the forefront of research and new developments in fertility medicine based at the Princess Anne University Hospital. The expert team of fertility professionals use the latest proven fertility techniques to develop a personal and compassionate treatment plan that offers patients the best chance of completing their family at the earliest opportunity.
Professor Nick Macklon, international leader in fertility medicine and Medical Director at Complete Fertility Centre says: “The AneVivo device allows fertilisation and early embryo development to happen in the mother’s womb rather than in the laboratory. Fertility and early embryos growth happens in a more physiological environment, receiving nutrition and signals from the mother rather than from the culture fluids used in the laboratory. There is increasing evidence that long term health of IVF babies may benefit from reducing the time spent in laboratory conditions. Studies have also shown that this approach, which allows the embryo and the mother to signal to each other, may result in the mother being better prepared and more receptive for embryo implantation. The preliminary results of this innovative procedure are encouraging.”
Source: Anecova